Search results for "Vaccines"
The waning and boosting of COVID-19 immunity
ACP and Annals of Internal Medicine's sixth COVID-19 forum examined progress amid the pandemic in the past year.
https://immattersacp.org/archives/2021/11/the-waning-and-boosting-of-covid-19-immunity.htm
1 Nov 2021
Latest COVID-19 research details local vaccine reactions, ineffective outpatient treatments
A case series described delayed skin reactions to vaccination, and randomized trials indicated that ivermectin, azithromycin, and convalescent plasma didn't help mildly ill patients. Several studies focused on the increase in alcohol use during the pandemic.
https://immattersacp.org/weekly/archives/2021/03/09/1.htm
9 Mar 2021
Remain vigilant this ‘twindemic’ season
The CDC is anticipating a resumption of seasonal flu activity in the U.S., but the potential effects of the COVID-19 pandemic this year remain unknown.
https://immattersacp.org/archives/2021/10/remain-vigilant-this-twindemic-season.htm
1 Oct 2021
Distribution plans, data on vaccines; NIH cautious on latest antibody treatment
The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020
Latest on COVID-19 and bamlanivimab, vaccines, long-term effects
Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
CDC recommends COVID-19 booster; ACP updates practice points for outpatient treatment
Everyone ages 6 months and older should get an updated COVID-19 vaccine to protect against a potentially serious outbreak this fall and winter, the CDC said last week.
https://immattersacp.org/weekly/archives/2023/09/19/1.htm
19 Sep 2023
CDC issues reminder on appropriate use of recombinant zoster vaccine
Early monitoring suggests that clinicians are confusing the administration and storage requirements of the older live attenuated virus vaccine with the recently approved recombinant zoster vaccine, the agency said.
https://immattersacp.org/weekly/archives/2018/06/05/5.htm
5 Jun 2018
ACIP updates flu vaccination recommendations
The Advisory Committee on Immunization Practices (ACIP) issued its annual update on flu vaccines, including a change in recommendations regarding vaccination of people with egg allergies.
https://immattersacp.org/weekly/archives/2023/08/29/1.htm
29 Aug 2023
High-dose flu vaccine may work better in elderly people
A high-dose flu vaccine induced significantly higher antibody responses and provided better protection against laboratory-confirmed influenza than did its standard-dose counterpart among persons 65 years of age or older, an industry-funded study found.
https://immattersacp.org/weekly/archives/2014/08/19/4.htm
19 Aug 2014